生命科学资讯
生物技术与制药领域的最新动态
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
生物科技投资公司Cormorant再获1.5亿美元，推进SPAC交易。
Biotech investor Cormorant secures $150M for another SPAC deal
Express Scripts考虑就FTC胰岛素价格诉讼达成和解
Express Scripts considering settlement in FTC insulin price lawsuit
2026年生物技术成功公式：信心、韧性与资金支持
The formula for biotech success in 2026: Confidence, resilience and funding
从检测到预防：赞助检测如何改变患者预后
From detection to prevention: How sponsored testing can transform patient outcomes
细胞疗法制造成功的关键：原材料选择的重要性
The crucial role of raw material selection for success in cell therapy manufacturing
赛诺菲将寻求批准备受瞩目的湿疹药物，尽管疗效结果喜忧参半。
Sanofi to seek approval of touted eczema drug despite mixed results
诺和诺德因“强劲”口服减肥药上市股价再创新高；Terns调整白血病药物合作协议。
Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal
国会关注解决医疗行业整合问题
Congress eyes tackling healthcare consolidation
投资者为“差异化”减肥药向Corxel注资2.87亿美元
Investors load Corxel with $287M for a ‘differentiated’ obesity pill
百时美施贵宝投资Janux的“掩蔽”T细胞接合剂技术。
Bristol Myers buys into Janux’s ‘masked’ T cell engagers
FDA公布新路径以加速多发性骨髓瘤药物开发
FDA lays out new path to speed development of multiple myeloma drugs
BioMarin前员工创立Mendra公司，致力于“革新”罕见病药物研发。
BioMarin vets form Mendra to ‘modernize’ rare disease drug development
Corvus公司湿疹药丸积极数据公布，股价飙升近三倍
Corvus shares nearly triple on positive data for eczema pill
强生瞄准千亿美元销售目标，癌症与免疫药物增长助力。
J&J eyes $100B in sales amid gains for cancer, immune drugs
Valneva因安全问题将撤出美国基孔肯雅热疫苗市场。
Valneva to withdraw Chikungunya vaccine from US amid safety woes
葛兰素史克以22亿美元收购Rapt，获取食物过敏药物。
GSK to buy Rapt in $2.2B deal for food allergy drug
Moderna癌症疫苗效果持续；IO Biotech考虑出售。
Moderna cancer vaccine holds up; IO Biotech considers a sale
凯莱拉的罗恩·雷诺谈中国关联初创企业如何在肥胖领域竞争
Kailera’s Ron Renaud on how a China-linked startup can compete in obesity